Stroke: new horizons in treatment
Lancet Neurol
.
2014 Jan;13(1):2-3.
doi: 10.1016/S1474-4422(13)70281-3.
Authors
Amrou Sarraj
1
,
James C Grotta
2
Affiliations
1
Department of Neurology University of Texas-Houston, 6410 Fannin Street, Houston, TX, 77030, USA.
2
Department of Neurology University of Texas-Houston, 6410 Fannin Street, Houston, TX, 77030, USA. Electronic address: james.c.grotta@uth.tmc.edu.
PMID:
24331780
DOI:
10.1016/S1474-4422(13)70281-3
No abstract available
Publication types
Review
MeSH terms
Animals
Fibrinolytic Agents / administration & dosage*
Humans
Infusions, Intra-Arterial
Randomized Controlled Trials as Topic / methods
Stroke / diagnosis
Stroke / drug therapy*
Treatment Outcome
Substances
Fibrinolytic Agents